< Back to latest news & events

Awards

HGF ranked ‘Gold’ in the Financial Times special report

July 2019

HGF has been ranked in ‘Gold’ for:

  • Chemistry & pharmacy
  • Electrical engineering & physics
  • Mechanical engineering
  • Biotechnology, food & healthcare

And ‘Silver’ for:

  • Materials & nanotechnology
  • IT & software

HGF has been ranked in the ‘Gold’ and ‘Silver’ bands in The Financial Times special report ‘Europe’s Leading Patent Law Firms’ published on 9 July 2019.

The firm is one of the largest firms of IP specialists in Europe, with 21 offices across the UK, Ireland,  Germany, The Netherlands, Austria and Switzerland, and is internationally recognised by its peers across these 6 core areas of technology.

Kate Taylor – Head of the Life Sciences team commented, “I am delighted to receive this level of recognition from our clients and peer group. The team comprises some exceptional attorneys with in-depth experience from in-house roles and academia. We have a wealth of expertise across the life sciences spectrum, and of particular note is the firm’s technical and legal reputation in the area of CRISPR, led by Cath Coombes and Dr Claire Irvine.” 

Matt Dixon – Head of the Engineering team commented, “Receiving a gold ranking is testament to the exceptional quality of the team we have built across Europe. The work we are undertaking in the fields of energy and medical devices are particularly key to the growth we have experienced.”

Dr Andrew Wells – Head of the Chemistry team commented, “The chemical team has grown significantly in the last 5 years and our client base is international and representative of all the key areas of chemistry and pharmaceuticals. We have a large number of attorneys who have in-house backgrounds and this has been a strong benefit for advising clients on IP strategies in this often-complex sector.”

The research was undertaken by The FT’s partner Statista, the market research provider, who compiled the list based on the survey results. A special report featuring the final list and articles exploring the work and role of European patent attorneys appeared in print in the Financial Times and on FT.com on July 9 2019. The survey collected peer recommendations from patent attorneys registered with the European Patent Office (EPO) as well as names from clients who have used a patent law firm in one of the 38 member states of the Munich-based EPO.

As a firm we are committed to building strong client relationships and delivering outstanding service from our offices in Germany, The Netherlands, Switzerland, Austria, Ireland and the UK we are delighted to have been ranked in Gold and Silver. HGF has a clear strategic growth plan under the leadership of Paul Sanderson, CEO.

The firm’s expansion across Europe has continued in 2019 with the merger of Patronus IP which expanded HGF offices into Munich, Heidelberg and Salzburg. This year the firm has also opened Dublin. Unlike other multi-office IP firms, HGF is one integrated firm that draws on its expertise across all offices and across all our attorney teams of: Law, Trade Marks, Electronics, Engineering, Chemistry and Life Sciences to assemble multi-disciplinary client teams that work together to meet clients’ needs.

For the full report see here.

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article